The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.
MedPage Today on MSN
How Do GLP-1 Drugs Stack Up for Cardiorenal Benefits in Diabetes?
"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback